Ciclosporin A inhibits endothelium-dependent vasodilatation and vascular prostacyclin production
- 1 June 1989
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 165 (1) , 165-169
- https://doi.org/10.1016/0014-2999(89)90785-1
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The long-term course of cyclosporine-associated chronic nephropathyKidney International, 1988
- Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human plateletsThrombosis Research, 1987
- THROMBOEMBOLIC COMPLICATIONS AND HAEMOSTATIC CHANGES IN CYCLOSPORIN-TREATED CADAVERIC KIDNEY ALLOGRAFT RECIPIENTSThe Lancet, 1985
- Cyclosporine: A New Immunosuppressive Agent for Organ TransplantationAnnals of Internal Medicine, 1984
- The endothelium-dependent vasodilator effect of acetylcholine: Characterization of the endothelial relaxing factor with inhibitors of arachidonic acid metabolismEuropean Journal of Pharmacology, 1984
- The Role of Endothelium in the Responses of Vascular Smooth Muscle to DrugsAnnual Review of Pharmacology and Toxicology, 1984
- Effect of cyclosporin A and inhibitors of arachidonic acid metabolism on blood flow and cyclo-oxygenase products in rat skin allograftsBritish Journal of Pharmacology, 1984
- Prostacyclin-induced contraction of isolated aortic strips from normal and spontaneously hypertensive rats (SHR)Prostaglandins, 1980